Join to View Full Profile
1033 Clifton Ave STE 201Clifton, NJ 07013
Phone+1 973-777-6444
Dr. Tassavor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Uconn School Of MedicineClass of 2018
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License 2023 - 2025
OH State Medical License 2022 - 2024
MA State Medical License 2018 - 2019
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- CGE25-104: The 31-GEP Identifies Patients With Early-Stage I-IIA Cutaneous Melanoma at High Risk of Melanoma-Specific and Overall Mortality.Harrison Nguyen, Christine N Bailey, Brian Martin, Sonia K Morgan-Linnell, Valentina I Petkov
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 1 citationsImproving melanoma reporting: The Ohio Model.Matthew DaCunha, Michael Tassavor, Madalyn Bland South, Brett Coldiron
Journal of the American Academy of Dermatology. 2024-11-01 - Wide Local Excision Before Sentinel Lymph Node Biopsy in Melanoma.Michael Tassavor, Madalyn Bland, Olivia Goldenberg, Bryan Tassavor, Brett Coldiron
Dermatologic Surgery. 2024-10-01
Press Mentions
Castle Biosciences’ Gene Expression Profile Test Effectively Predicts Sentinel Lymph Node PositivityOctober 6th, 2023- Castle Biosciences to Present New Data Highlighting the Clinical Value of Its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual MeetingMarch 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
